Are Recurrent UTIs Normal with Adenomyosis?

Are Recurrent UTIs Normal with Adenomyosis?

Recurrent UTIs are not a random coincidence in women with adenomyosis — they are a predictable consequence of the condition. The enlarged, inflamed uterus compresses the bladder and urethra, alters pelvic floor mechanics, and drives systemic immune dysregulation that lowers local mucosal defenses. That said, recurrent UTIs are never something you simply accept; they signal that the underlying inflammation needs to be addressed.

---

What Is Adenomyosis and Why Does It Affect the Urinary Tract?

Adeномyosis occurs when endometrial-like tissue grows into the muscular wall of the uterus (the myometrium) rather than staying within the uterine cavity. The result is a uterus that is diffusely enlarged, often tender, and perpetually inflamed throughout the menstrual cycle — and frequently beyond it.

This structural change has direct anatomical consequences. The bladder sits directly anterior to the uterus. When the myometrium thickens — sometimes doubling or tripling normal uterine volume — it physically impinges on bladder capacity and can kink the ureteral angle. Incomplete bladder emptying is one of the most well-established risk factors for recurrent UTIs, because residual urine provides a growth medium for uropathogens like E. coli (Foxman 2014; PMID: 24280536).

Beyond anatomy, adenomyosis is an inflammatory disease. Elevated prostaglandins, interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) have all been documented in women with adenomyosis (García-Solares et al., Fertility and Sterility 2018; PMID: 29548709). Systemic immune activation of this type suppresses the local mucosal immune response in the urogenital tract — the very immune layer that normally prevents bacteria from establishing a foothold on bladder epithelium.

Finally, many women with adenomyosis also carry a concurrent diagnosis of endometriosis, PCOS, or hormonal dysregulation, each of which independently alters vaginal microbiome composition and urinary tract vulnerability. If you are also navigating hormonal shifts, the connection between recurrent UTIs and hormonal conditions like PMDD follows similar inflammatory pathways worth understanding.

---

How Chronic Inflammation Creates a Recurring UTI Cycle

The link between systemic inflammation and recurrent UTIs is mechanistic, not speculative. Here is how the cycle typically operates in adenomyosis:

1. Elevated prostaglandins irritate bladder smooth muscle, causing urgency and incomplete voiding.
2. Residual urine allows uropathogens to multiply before the bladder can clear them.
3. Suppressed mucosal IgA — the antibody that coats and protects the urothelium — leaves the bladder lining less able to repel bacteria.
4. Antibiotic courses prescribed for each UTI progressively deplete the vaginal Lactobacillus population, the organism primarily responsible for maintaining a protective low-pH environment that deters uropathogen ascent.
5. Microbiome disruption increases susceptibility to the next UTI, restarting the cycle.

A 2019 prospective cohort study published in European Urology found that women with chronic pelvic inflammatory conditions had a 2.3-fold higher rate of recurrent UTIs compared with matched controls, with microbiome disruption identified as a primary mediating variable (Anger et al., European Urology 2019; PMID: 30935742).

This cycle is self-reinforcing, which is why simply completing another antibiotic course rarely resolves the pattern. Addressing the inflammatory driver — adenomyosis — is what breaks it.

---

The Psychological Weight: What Chronic Illness Does to Your Nervous System

Living with adenomyosis and recurrent UTIs is not just a physical burden. The psychological toll is substantial, measurable, and vastly underreported in clinical settings.

Chronic pain conditions consistently activate the hypothalamic-pituitary-adrenal (HPA) axis. When pain signals are persistent — as they are in adenomyosis — cortisol dysregulation becomes structural, not situational. Elevated evening cortisol disrupts sleep architecture, impairs hippocampal function (contributing to brain fog and memory gaps), and reduces the threshold for pain sensitization, meaning the nervous system literally becomes better at generating pain signals over time (Vierck et al., Pain 2006; PMID: 16697110).

The psychiatric comorbidity data are stark. A large Taiwanese registry study found that women with endometriosis — a close disease relative of adenomyosis — had significantly elevated rates of depression, anxiety, and sleep disorders compared with age-matched controls (Chao et al., Human Reproduction 2020; PMID: 32076718). Adenomyosis studies report similar patterns, with many women describing a gradual erosion of self-trust: they begin to doubt their own symptom reports after years of being dismissed.

Recurrent UTIs compound this. Each infection brings urgency, burning, and the social anxiety of needing bathroom access at all times. The unpredictability of flares — weeks of relative calm followed by sudden, disabling symptoms — is itself a stressor that activates threat-detection circuits in the amygdala and maintains a chronic low-grade stress response.

This psychological burden is not incidental. It is a physiological consequence of the disease that deserves the same clinical attention as the anatomical findings. If you are in perimenopause and navigating both hypothyroidism and recurrent UTIs, the compounding immune and hormonal effects are explored in detail in this piece on recurrent UTIs in perimenopause with hypothyroidism.

---

Does the Uterus Size on Imaging Tell the Full Story?

A common point of confusion — and frustration — for women with adenomyosis is receiving an ultrasound report that reads "uterus within normal limits" while experiencing debilitating symptoms. This is not a contradiction in the radiology; it is a limitation of the imaging.

Adeномyosis is notoriously difficult to visualize on standard pelvic ultrasound, particularly in its early or diffuse forms. A 2017 systematic review and meta-analysis in Ultrasound in Obstetrics and Gynecology found that transvaginal ultrasound has a sensitivity of only 72% and a specificity of 81% for diagnosing adenomyosis — meaning a meaningful proportion of confirmed cases appear "normal" on imaging (Harada et al., UOG 2016; PMID: 26970592). MRI is the gold standard, with sensitivity exceeding 90%, but it is rarely ordered as a first-line test.

What this means practically: a normal-looking uterus on ultrasound does not rule out adenomyosis, and it does not explain away your symptoms. The inflammatory cytokine environment that drives recurrent UTIs, bladder pressure symptoms, and dysmenorrhea can be fully active even when the imaging is unremarkable.

Women who pursue MRI after a normal ultrasound frequently receive their adenomyosis diagnosis only at that stage. If your symptoms persist and your imaging is inconclusive, advocating for an MRI is clinically reasonable.

---

Nutrient Deficiencies That Worsen Both Conditions

Chronic inflammation consumes micronutrients at an accelerated rate. Women with adenomyosis-related heavy menstrual bleeding are at particular risk for iron deficiency, which itself impairs immune function and mucosal repair. But several other nutrient gaps directly worsen UTI susceptibility:

Vitamin D deficiency is particularly important here. A randomized controlled trial published in JAMA Internal Medicine found that vitamin D supplementation significantly reduced the rate of recurrent UTIs in women with documented deficiency (Hertting et al., JAMA Intern Med 2010; PMID: 20548009). Given that chronic inflammatory diseases reliably deplete vitamin D through increased metabolic turnover, testing and optimizing D3 levels is a rational early intervention.

Omega-3 fatty acids (EPA and DHA) merit specific attention. By competitively inhibiting arachidonic acid metabolism, omega-3s reduce the prostaglandin load that drives both adenomyosis-related pelvic pain and bladder smooth muscle irritability. For a deeper look at how omega-3s interact with hormonal conditions, this overview of omega-3 and menopause symptoms covers the same anti-inflammatory mechanism in a related hormonal context.

Probiotics are the third pillar. The genus Lactobacillus — specifically L. rhamnosus and L. reuteri — has been shown in randomized trials to reduce UTI recurrence rates by 48–73% when used as maintenance therapy after antibiotic treatment (Beerepoot et al., Archives of Internal Medicine 2012; PMID: 22782196). If you are also dealing with perimenopause alongside these symptoms, the evidence on probiotics for perimenopause is directly relevant to your vaginal microbiome.

---

What This Means for Your Formula

Ones builds personalized supplement formulas by analyzing blood work, wearable data, and health history through an AI health practitioner — which means the nutrient gaps most relevant to your specific situation, not a generic women's health stack, are what get addressed.

For someone managing adenomyosis with recurrent UTIs, three ingredients are particularly likely to appear in a Ones formula based on the mechanisms above:

Vitamin D3 + K2 (MK-7) — Ones includes vitamin D3 paired with menaquinone-7 (MK-7) at doses calibrated to your blood levels. Given the direct evidence linking vitamin D deficiency to UTI recurrence and the reliable depletion of D3 in chronic inflammatory conditions, this is frequently a high-priority addition when labs confirm insufficiency.

Omega-3 (EPA/DHA) — At clinically meaningful doses of EPA and DHA, omega-3 supplementation reduces the prostaglandin burden that drives both adenomyosis-related inflammation and bladder smooth muscle irritability. Ones sources pharmaceutical-grade omega-3 and doses to clinical ranges, not the sub-therapeutic amounts common in off-the-shelf products.

Zinc — Mucosal immunity depends on zinc-dependent T-cell function and epithelial repair processes. Frequent antibiotic courses deplete zinc stores, and Ones includes zinc at dosing levels aligned with research on immune restoration rather than simple deficiency prevention.

Because Ones formulas are built from your actual data, the formula you receive reflects your specific deficiencies and inflammatory drivers — not what works on average.

---

Key Takeaways

• Recurrent UTIs in women with adenomyosis are mechanistically explained, not coincidental — uterine enlargement, bladder compression, and systemic immune dysregulation all contribute.
• Chronic inflammation suppresses mucosal IgA and creates conditions for bacterial colonization; each antibiotic course further depletes the protective vaginal microbiome.
• Normal pelvic ultrasound findings do not rule out adenomyosis — transvaginal ultrasound misses a significant proportion of confirmed cases, and MRI is the appropriate next step when symptoms persist.
• The psychological burden of living with chronic pelvic pain and recurrent UTIs is physiologically real: HPA axis dysregulation, cortisol-driven sleep disruption, and nervous system sensitization are measurable consequences, not attitude problems.
• Key nutrient interventions — Vitamin D3, omega-3 (EPA/DHA), zinc, and probiotic Lactobacillus strains — address specific links in the UTI recurrence chain and are supported by clinical trial data.
• Resolving the recurrent UTI pattern requires addressing the inflammatory driver (adenomyosis), not just treating each infection in isolation; work with a healthcare provider who takes both conditions seriously.